Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Recent patents reveal novel antidiabetic agents

Feb. 22, 2006

Planned Oxycyte phase II trial placed on hold for protocol revisions

Feb. 22, 2006

Dosing begins in phase III study of ospemifene for vaginal atrophy

Feb. 22, 2006

Fispemifene begins phase II trial to treat symptoms of andropause

Feb. 22, 2006

FDA approval for new oral contraceptive Loestrin 24 Fe

Feb. 21, 2006

Rimonabant receives approvable, nonapprovable letters

Feb. 21, 2006

NDA submission for Bio-E-Gel to treat moderate to severe hot flashes

Feb. 20, 2006

Organon to close LIFT study of tibolone in elderly osteoporotic patients

Feb. 20, 2006

Novel 5-HT2C receptor agonists emerge from Athersys R&D

Feb. 17, 2006

Januvia NDA accepted for review

Feb. 17, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...